Acuta Capital Partners’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-12,917
Closed -$1.52M 41
2019
Q4
$1.52M Buy
+12,917
New +$1.52M 0.38% 32